Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation - (Details)

v3.21.2
Basis of Presentation - (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Dilutive warrants 0 282,472
Common Stock [Member]    
Antidilutive securities excluded from computation of earnings per share   15,063,900
Common Stock [Member] | Over-Allotment Option [Member]    
Antidilutive securities excluded from computation of earnings per share   75,000
Warrant [Member]    
Antidilutive securities excluded from computation of earnings per share 1,529,200 75,000
Restricted Stock [Member]    
Antidilutive securities excluded from computation of earnings per share   2,297,300
UPOs [Member]    
Antidilutive securities excluded from computation of earnings per share 7,600